Scavenger receptor CD36 is essential for the cerebrovascular oxidative stress and neurovascular dysfunction induced

Laibaik Park1, Gang Wang, Ping Zhou

  • 1Division of Neurobiology, Department of Neurology and Neuroscience, Weill Medical College of Cornell University, New York, NY 10065, USA.

Insights

The scavenger receptor CD36 links amyloid-β (Aβ) to vascular oxidative stress, a key factor in Alzheimer's dementia (AD) neurovascular dysfunction. Targeting CD36 may offer a therapeutic strategy for AD-related cerebrovascular issues.

Area of Science:

  • Neuroscience
  • Vascular Biology
  • Biochemistry

Background:

  • Cerebrovascular dysfunction is increasingly implicated in Alzheimer's dementia (AD) pathogenesis.
  • Amyloid-β (Aβ) peptides exert vascular effects, largely via NADPH oxidase-generated reactive oxygen species.
  • The precise mechanisms connecting Aβ to vascular oxidative stress remain unclear.

Purpose of the Study:

  • To elucidate the mechanisms linking Aβ to NADPH oxidase-dependent vascular oxidative stress.
  • To investigate the role of the scavenger receptor CD36 in Aβ-induced neurovascular dysfunction.
  • To determine if CD36 is a potential therapeutic target for AD-related cerebrovascular dysfunction.

Main Methods:

  • Topical application of Aβ1-40 onto the somatosensory cortex of wild-type (WT) and CD36-null (CD36(0/0)) mice.
  • Intracerebral arterial infusion of Aβ1-40 in WT mice with and without CD36 blocking antibodies.
  • Assessment of neurovascular dysfunction in CD36(0/0) mice and Tg2576 transgenic AD model mice.
  • Measurement of vascular oxidative stress in response to Aβ1-40.

Main Results:

  • CD36 is essential for Aβ1-40-induced vascular oxidative stress and neurovascular dysfunction.
  • Aβ1-40 failed to attenuate cerebral blood flow increases in CD36-null mice.
  • CD36 deficiency prevented Aβ-induced neurovascular dysfunction in Tg2576 mice, despite elevated Aβ levels.
  • CD36 mediates vascular oxidative stress induced by exogenous Aβ1-40 and observed in AD models.

Conclusions:

  • CD36 acts as a critical mediator linking Aβ1-40 to NADPH oxidase-dependent vascular oxidative stress.
  • This oxidative stress contributes significantly to the neurovascular dysfunction observed in Alzheimer's dementia.
  • CD36 represents a promising therapeutic target for mitigating cerebrovascular dysfunction in AD.